Reasoning that mnt heterozygosity might be insufficient to enhance susceptibility to Myc-driven apoptosis in vitro but might have conferred increased susceptibility in vivo to particular physiological signals or to other oncogenic mutations, we quantitated cell death in sections of mnt+/+versus mnt+/− Eμ-myc lymphomas. This evidence concerns the gene MYC and lymphoma.